Skip to main content
. 2013 Oct-Dec;25(4):270–278. doi: 10.5935/0103-507X.20130047

Table 1.

General characteristics of the sample according to the groups

  Severe sepsis Septic shock  
  Lactate <4mmol/L (N=1.018) Lactate >4mmol/L (N=162) Lactate <4mmol/L (N=549) Lactate >4mmol/L (N=219) p value
  Severe sepsis Cryptic shock Vasoplegic shock Dysoxic shock  
Age (years) 60±22b 60±21d 66±18 63±18 <0.001
Males 458 (45) 81 (50) 267 (49) 109 (50) 0.321
APACHE II 15±6a,b,c 17±7d,e 20±8f 24±8 <0.001
SOFA 3 [2-5]b,c 4[2-6]d,e 9 [7-10]f 10 [8-13] <0.001
Lactate (mmol/L) 1.78 [1.2-2.5] 5.25 [4.5-6.6] 2.0 [1.3-2.7] 6.10 [4.8-8.8] <0.001
Place of sepsis diagnosis         <0.001
    Emergency room 500 (49)b 95 (59)d 201 (37) 110 (50) <0.001
    Ward 390 (38)b 46 (28) 167 (30) 72 (33) 0.004
    ICU 128 (13)b 21 (13) 181 (33) 37 (17) <0.001
Site of infection         0.001
    Pneumonia 350 (34)b 55 (34) 149 (27) 60 (27) 0.012
    Urinary tract 165 (16)c 32 (20) 99 (18) 54 (25) 0.027
    Abdominal 147 (14) 28 (17) 94 (17) 34 (16) 0.501
    Catheter-related 63 (6) 10 (6) 48 (9) 23 (11) 0.070
    Surgical wound 51 (5) 14 (9) 43 (8) 15 (7) 0.084
    Meningitis 58 (6) 7 (4) 16 (3) 11 (5) 0.100
    Bone 25 (3) 1 (1) 9 (2) 3 (1) 0.317
    Endocarditis - 1 (1) 2 (1) 1 (1) 0.188
    Others 159 (16)a,c 14 (9)d 89 (17)e 18 (9) 0.004
Clinical presentation at diagnosis          
    Fever 359 (35)c 47 (29) 152 (28) 46 (21) <0.001
    Hypothermia 165 (16)c 29 (18) 102 (19) 60 (27) 0.002
    Tachycardia 780 (77)a 143 (88)d,e 416 (76) 172 (79) 0.006
    Tachypnea 562 (55) 100 (62) 290 (53) 131 (60) 0.121
    Leukopenia 51 (5)c 8 (5)e 31 (6)f 25 (11) 0.003
    Leukocytosis 490 (48) 80 (49) 284 (52) 101 (46) 0.444
    Hyperglycemia 156 (15)b 34 (21) 138 (25) 49 (22) <0.001
    Decreased level of consciousness 316 (31)b 62 (38) 224 (41) 89 (41) <0.001
    Arterial hypotension 496 (49)b,c 61 (38)d,e 549 (100) 219 (100) 0.001
Treatment received at diagnosis          
    Collection of blood culture 870 (86)c 141 (87) 445 (81) 177 (81) 0.050
    Antibiotics 903 (89) 141 (87) 475 (87) 193 (88) 0.632
    Time to first antibiotic dose (hours) 0.6 [0.2-1.6] 0.5 [0.1-1.8] 0.7 [0.2-2.3] 0.5 [0.0-2.3] 0.234
    Adequate volume expansion and vasopressor if necessary 1.010 (99)c 156 (96) 512 (93) 214 (98) <0.001
Outcomes          
    Hospital mortality 16.8 (14.4-19.1) 35.2 (28.4-43.2) 48.1 (43.7-52.1) 60.3 (53.9-67.1) <0.001
    Length of stay (days)          
        ICU 3 [1-7]d,e 4 [2-9]d 7 [3-15]f 4 [1-11] <0.001
            Non-survivors 8 [3-16]c 6 [2-17]e 8 [3-16]f 2 [1-8] <0.001
            Survivors 3 [1-5]b,c 3 [1-7]d,e 7 [4-15] 8 [4-13] <0.001
        Hospital 10 [6-17]b,c 9 [5-18]d 14 [7-28]f 8 [1-18] <0.001
            Non-survivors 12 [6-23]b,c 9 [3-22]e 9 [3-19]f 2 [1-9] <0.001
            Survivors 10 [6-17]b,c 10 [7-17]d>,e 19 [11-33] 17 [11-27] <0.001

APACHE - Acute Physiologic Chronic Health Evaluation; SOFA - Sequential Organ Failure Assessment; ICU - intensive care unit. Results expressed as number (%), mean±standard deviation or median (25%-75%).

* Results s expressed in % (confidence interval 95%).

a

Severe sepsis versus cryptic shock;

b

severe sepsis versus vasoplegic shock;

c

severe sepsis versus dysoxic shock;

d

cryptic shock versus vasoplegic shock;

e

cryptic shock versus dysoxic shock;

f

vasoplegic shock versus dysoxic shock.